Insider Transactions in Q1 2026 at Apogee Therapeutics, Inc. (APGE)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2026
|
Carl Dambkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,700
-2.05%
|
$1,458,600
$78.53 P/Share
|
|
Jan 07
2026
|
Carl Dambkowski Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,025
+5.72%
|
$308,550
$22.86 P/Share
|
|
Jan 06
2026
|
Jane Henderson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,000
-1.07%
|
$160,000
$80.0 P/Share
|
|
Jan 02
2026
|
Jane Henderson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-1.56%
|
$444,000
$74.66 P/Share
|